Faced with these conflicting results, doubts arose regarding the potential danger of the drug, and prescriptions for digoxin for hospitalized HF patients plummeted, particularly in the United States.

"Hearst Magazines and AOL may earn commission or revenue on some items through these links." "Mix 1 scoop (5,000 mg) in water or your favorite beverage 3 to 4 times per day for the first 5 to 7 days.

BARCELONA, Spain—Heart failure (HF) patients who have reduced or mildly reduced ejection fraction derive better outcomes when low-dose digoxin is added on top of contemporary guideline-directed ...

Please provide your email address to receive an email when new articles are posted on . Digitalis glycosides, such as digoxin, may prevent worsening HF events in patients with LVEF of 50% or less.

A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. This emerges from three studies led by UMCG cardiologists Dirk Jan van Veldhuisen, Kevin Damman, ...

Low-dose digoxin did not significantly reduce the primary outcome. Over a median follow-up of 36.5 months, 238 primary-outcome events occurred in 131 of 500 patients in the digoxin group, while 291 ...

A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. This emerges from three studies led by UMCG cardiologists Dirk Jan van Veldhuisen, Kevin Damman, ...

Christina is a freelance writer, registered dietitian, and sustainable food systems professional. She feels most passionately about improving the health of the planet and its people through sharing ...

Heart drugs called digitalis glycosides, which include digoxin and digitoxin, have been used for centuries, but their place in the modern treatment of heart failure remains undefined. Results were ...

Top NBA hopeful Darryn Peterson said a popular supplement left him with debilitating symptoms that sidelined his game and made him fear for his life. Peterson, 19, recalled being rushed to the ...

Data from the phase 2/3 DEVOTE trial demonstrate significant motor function improvements in patients treated with the high-dose nusinersen regimen. The Food and Drug Administration (FDA) has approved ...